Symptoms and Testing information for Immunohistochemistry PDL1 SP142 Test

Symptoms and Testing information for Immunohistochemistry PDL1 SP142 Test

In the realm of medical diagnostics, the Immunohistochemistry PDL1 SP142 Test stands out as a significant advancement, especially in the context of cancer treatment and management. This test, offered by DNA Labs UAE, is pivotal in identifying the presence of the Programmed Death-Ligand 1 (PD-L1) protein in cancer cells, which plays a crucial role in the body’s immune response to cancer. Understanding the symptoms that necessitate this test, its implications, and its cost is crucial for patients and healthcare providers alike.

Understanding the Immunohistochemistry PDL1 SP142 Test

The Immunohistochemistry PDL1 SP142 Test is a specialized diagnostic tool used primarily to assess the expression of the PD-L1 protein in tumor cells or immune cells surrounding the tumor. The presence and level of PD-L1 expression are critical in determining the suitability of certain immunotherapies for cancer treatment, particularly in conditions like non-small cell lung cancer (NSCLC), bladder cancer, and triple-negative breast cancer, among others. This test provides essential information that helps in tailoring the most effective treatment plans for cancer patients.

Symptoms Necessitating the PDL1 SP142 Test

While the PDL1 SP142 Test is not directly ordered based on symptoms alone, certain clinical scenarios and cancer diagnoses may prompt a healthcare provider to recommend this test. These scenarios generally include:

  • A diagnosis of specific types of cancer known to potentially express PD-L1, such as NSCLC, bladder cancer, or triple-negative breast cancer.
  • Assessing the tumor’s characteristics to determine the feasibility of immunotherapy as a treatment option.
  • Evaluating the progression of the disease or the effectiveness of ongoing treatment, particularly if immunotherapy is part of the regimen.

It’s important to consult with a healthcare provider to understand if this test is suitable for your specific condition and how it might impact your treatment options.

Cost of the Immunohistochemistry PDL1 SP142 Test

At DNA Labs UAE, the cost of the Immunohistochemistry PDL1 SP142 Test is set at 2700 AED. This cost is reflective of the sophisticated technology and expertise required to accurately assess PD-L1 expression and provide reliable results that can significantly influence treatment decisions. It’s advisable to check with your insurance provider to understand the extent of coverage for this test, as policies vary widely.

Conclusion

The Immunohistochemistry PDL1 SP142 Test is a critical diagnostic tool in the management of certain types of cancer, enabling a more personalized approach to treatment. Understanding when this test is recommended and its implications are important steps in navigating your cancer treatment journey. With a cost of 2700 AED at DNA Labs UAE, it represents a significant investment in the pursuit of the most effective treatment strategy for patients facing PD-L1 expressive cancers.

For more detailed information about the Immunohistochemistry PDL1 SP142 Test and to understand how it can be a part of your or your loved one’s treatment plan, visit DNA Labs UAE.

Leave a Reply

Your email address will not be published. Required fields are marked *

Home Sample Collection

Sample Collection at Home

100% Accuarte results

Each sample is tested twice

Reports from Accrediated Labs

Get Tested from certified labs

100% Secure Checkout

PayPal / MasterCard / Visa